Company Filing History:
2 out of 2,971 
1 out of 73 
1 out of 15,528 
Years Active: 2020-2024
Title: Innovations by Alejandro J Laguna Sanz
Introduction
Alejandro J Laguna Sanz is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of diabetes management. With a focus on innovative solutions, he holds two patents that address critical challenges faced by individuals with diabetes.
Latest Patents
His latest patents include the "Prevention of post-bariatric hypoglycemia using a novel glucose prediction algorithm" and "Predictive control model for the artificial pancreas using past predictions." The first patent presents a hypoglycemia prediction algorithm specifically designed for the unique postprandial glycemic patterns characteristic of post-bariatric hypoglycemia (PBH). This algorithm predicts impending hypoglycemia by collecting data from sensors that measure glucose concentration in the bloodstream. The data is processed to determine whether predicted glucose concentrations fall below a hypoglycemic threshold, enabling the enactment of an impending hypoglycemia protocol. The second patent outlines methods and devices for adaptively tuning a zone-based Model Predictive Control (MPC) controller. This involves determining residuals based on prediction models, calculating a trust index to quantify uncertainty, and tuning the MPC controller in real-time based on this trust index.
Career Highlights
Alejandro has worked with prestigious institutions such as Harvard College and Joslin Diabetes Center, Inc. His work has been instrumental in advancing diabetes care through innovative technological solutions.
Collaborations
He has collaborated with notable professionals in the field, including Eyal Dassau and Francis J Doyle, III. These collaborations have further enhanced the impact of his inventions.
Conclusion
Alejandro J Laguna Sanz is a pioneering inventor whose work in diabetes management through innovative algorithms and control models is making a significant difference in the lives of many. His contributions continue to shape the future of diabetes care.